نتایج جستجو برای: benign hyperplasia of prostate

تعداد نتایج: 21190603  

Journal: :nephro-urology monthly 0
mohammad reza sharif department of pediatrics, kashan university of medical sciences, kashan, ir iran amirreza shaabani department of urology, kashan university of medical sciences, kashan, ir iran hossein mahmoudi department of urology, kashan university of medical sciences, kashan, ir iran hassan nikoueinejad department of nephrology and urology research center, baqiyatallah university of medical sciences, tehran, ir iran; department of nephrology and urology research center, baqiyatallah university of medical sciences, baqiyatallah hospital, mollasadra ave., vanak sq., p.o. box: 19395-5487, tehran, ir iran. tel: +98-2181262073, fax: +98-3615551112 hossein akbari department of biostatistics, kashan university of medical sciences, kashan, ir iran behzad einollahi department of nephrology and urology research center, baqiyatallah university of medical sciences, tehran, ir iran

background: recently, the development of new biomarkers as prognostic and predictive markers in prostate cancer has been crucial. objectives: this study was aimed to determine whether serum vascular endothelial growth factor (vegf) levels would be a prognostic marker or risk assessment factor in patients with prostate cancer and to investigate whether it could differentiate cancerous tissue fro...

1997
Shivaji Gupta G.C Prasad

The Vasti therapy is highly effective in the management of benign prostate Hyperplasia. It deceases the weight-of prostate, residual urine and free serum testosterone level.

Gholamreza Pourmand, Abbas Basiri, Mohammad Taghi Akbari, Seyedeh Maryam Seyedolmohadessin, Zahra Nourmohammadi,

Background: Prostate cancer is the second form of cancer among men worldwide. For early cancer detection, we should identify tumors in initial stages before the physical signs become visible. The present study aims to evaluate the diagnostic value of cell-free DNA (cfDNA), its comparison with prostate-specific antigen (PSA) level in prostate cancer screening and also in patients with localized ...

Journal: :Actas urologicas espanolas 2014
J M Benejam-Gual A Sanz-Granda R García-Miralles Grávalos A Severa-Ruíz de Velasco J Pons-Viver

INTRODUCTION Transurethral resection of the prostate is the gold standard of surgical treatment of lower urinary tract symptoms associated to benign prostate hyperplasia. The new Green Light Photovaporization has been shown to be an alternative that is as effective for this condition as the transurethral resection of the prostate. OBJECTIVES To compare the efficiency of Green Light Photovapor...

2005
W. M. Kwiatek A. Banas K. Banas G. Dyduch G. Falkenberg

Enlargement of the prostate is an age-related, physiological process that is unique in human tissue. The prostate gland is the most common site of neoplastic disorders in men. Despite the growing impact of the various prostate diseases in terms of morbidity and mortality, the pathogenesis of benign prostate hyperplasia (BPH) and prostate cancer remains poorly understood. This reflects the compl...

Background: Benign prostatic hyperplasia (BPH) is the most common benign tumor in men. The etiology of BPH is still unresolved and multiple systems are likely to be involved. The effects of diabetes on urinary system are a risk factor for BPH. We then assessed the effects of diabetes on the parameters related to BPH, especially weight and volume. Methods: This study was conducted on patients...

Craniofacial skeletal metastasis is a rare presentation of advanced prostate cancer. This is a report of a 69-year-old man who presented with numbness of the right lower lip and recently ill-fitting lower denture. Based on the medical history of benign prostate hyperplasia (BPH) and suspicion of a metastatic tumor, prostate core needle biopsy was performed. Histology of the prostate biopsy con...

Abolhasani, Maryam , Angaji, Seyed Abdolhamid , Beikzadeh, Behnaz ,

Background and Objective: Prostate cancer is among the five common cancers in males. It is second cancer in terms of the age-standardized rate (ASR) (ASR=16.6) in Iran. The rs2735839 G/A, an intergenic polymorphism is located on chromosome 19q13.33 at 600 base pairs of the KLK3 gene untranslatable region. This gene which codes prostate-specific antigen (PSA) is used in the screening and diagnos...

Journal: :National journal of laboratory medicine 2023

Introduction: Benign Hyperplasia of the Prostate (BHP) and prostate cancer comprise about 90% all diseases gland. An increase in serum Specific Antigen (PSA) is an indicator underlying hyperplasia, inflammation, or cancer. Mast cells are found both inflamed tumour tissue. Aim: To find correlation mast cell count with age, weight prostate, PSA level, thereby distinguishing between benign inflamm...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید